http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022036335-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d452ebbe234b18c80d0462dc24578da3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8e7faf57214f094b5210a8ac5d4feef |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-22 |
| filingDate | 2021-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_631617c3081a81de8e4e122e6c6b0f91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17ea96241f4cbef6b4a4f9eaa74a5eab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0cc2f10d806cc14006338c0c86ae004 |
| publicationDate | 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022036335-A1 |
| titleOfInvention | Organ transplant perfusion solution modifications using bryostatin-1 |
| abstract | Solutions and methods for preserving tissues or organs comprising administering to a harvested tissue or a harvested organ a composition comprising bryostatin-1, or a pharmaceutically acceptable salt, analog, or stereoisomer thereof and a protein free carrier including Polyethylene glycol-Ethanol-Tween 80 for between 10.0 minutes and 1.0 minutes and washing the tissue or organ with a saline solution after administering the composition, wherein the saline solution is substantially free of bryostatin-1, or a pharmaceutically acceptable salt, analog, or stereoisomer thereof, the composition is administered only less than 30 minutes before the tissue or organ is transplanted into a patient in need thereof, and a concentration of bryostatin-1 in an intravenous location of the tissue or organ after washing is below 10-9 M, below 10-10 M, or effectively zero M. |
| priorityDate | 2020-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.